SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-18-000115
Filing Date
2018-08-14
Accepted
2018-08-14 20:43:31
Documents
1
Period of Report
2018-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2814
  Complete submission text file 0001250853-18-000115.txt   4238
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 248 ROUTE 25A, NO. 2 EAST SETAUKET NY 11733
Business Address
Ho Sze Chun Winson (Reporting) CIK: 0001750177 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51476 | Film No.: 181019580